ANAB ANAPTYSBIO, INC: institutional ownership and insider trading
223 funds reported holding $2.14B of ANAPTYSBIO, INC in their latest 13F filings; in Q2 2026 funds net bought $134M, with 43 new positions and 35 funds selling out; over the last 12 months insiders bought $0 and sold $9.75M on the open market; over its last four quarters it reported revenue of $232M and net income of −$26.8M.
ANAB revenue and earnings
- Quarter ended Mar 31, 2026: revenue $25.6M, net income −$52.9M, EPS -1.84
- Quarter ended Dec 31, 2025: revenue $108M, net income $49.6M, EPS 1.66
- Quarter ended Sep 30, 2025: revenue $76.3M, net income $15.1M, EPS 0.52
- Quarter ended Jun 30, 2025: revenue $22.3M, net income −$38.6M, EPS -1.34
Famous investors holding ANAB
- Izzy Englander (Millennium Management): $55.5M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $36.4M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $17.8M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $3.94M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $27.9M, 0.0% of the portfolio
Largest institutional holders of ANAB
- EcoR1 Capital, LLC — $532M
- BlackRock, Inc. (BLK) — $124M
- TANG CAPITAL MANAGEMENT LLC — $89.8M
- STATE STREET CORP (STT, STT-PG) — $86.8M
- VANGUARD GROUP INC — $74.9M
- VANGUARD CAPITAL MANAGEMENT LLC — $61.2M
- Affinity Asset Advisors, LLC — $55.8M
- MILLENNIUM MANAGEMENT LLC — $55.5M
- Sanofi (SNY, SNYNF) — $55.5M
- Woodline Partners LP — $48.4M
Recent ANAB insider trades
- Oct 1, 2026: Renton Hollings sold 5,000 shares ($249K)
- Mar 30, 2026: Schmid John P. sold 20,645 shares ($1.16M)
- Mar 27, 2026: Faga Daniel sold 17,679 shares ($1.09M)
- Feb 11, 2026: Loumeau Eric J sold 10,000 shares ($540K)
5%+ owners
- Sirenia Capital Management LP: 5.0% (Schedule 13G/A, filed Aug 14, 2026)